Deep Brain Stimulation in Parkinson's Disease Market Size, Share, and Outlook, 2025 Report- By Product (Single Channel, Dual Channel), By End-User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers), 2021-2032

Deep Brain Stimulation in Parkinson's Disease Market Outlook

Deep Brain Stimulation in Parkinson's Disease Market Size is forecast to register an optimistic growth rate of 11.2% from 2025 to 2032.. The Deep Brain Stimulation in Parkinson's Disease market is a thriving business that is poised to keep growing and presents potential growth opportunities for companies across the industry value chain.

The comprehensive market research report presents 12-year historic and forecast data on Deep Brain Stimulation in Parkinson's Disease segments across 22 countries from 2021 to 2032. Key segments in the report include By Product (Single Channel, Dual Channel), By End-User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers). Over 70 tables and charts showcase findings from our latest survey report on Deep Brain Stimulation in Parkinson's Disease markets.

Deep Brain Stimulation in Parkinson's Disease Market Insights, 2025

The deep brain stimulation (DBS) in Parkinson’s disease market is witnessing significant growth as DBS remains one of the most effective surgical interventions for managing motor symptoms in advanced Parkinson’s cases. DBS targets brain structures such as the subthalamic nucleus (STN) and globus pallidus internus (GPi), helping to reduce tremors, rigidity, and dyskinesia. The increasing prevalence of Parkinson’s disease, alongside the limitations of pharmacological treatments such as levodopa-induced dyskinesia, is driving demand for DBS therapy. Recent advancements, including directional leads for precise stimulation, AI-driven programming for personalized therapy, and non-invasive DBS alternatives, are enhancing treatment effectiveness. Growing clinical research into early-stage Parkinson’s intervention with DBS is further expanding market potential.

Five Trends that will define global Deep Brain Stimulation in Parkinson's Disease market in 2025 and Beyond

A closer look at the multi-million global market for Deep Brain Stimulation in Parkinson's Disease identifies rapidly shifting consumer preferences across categories. By focusing on growth and resilience, leading Deep Brain Stimulation in Parkinson's Disease companies are prioritizing their investments across categories, markets, and geographies. The report analyses the most important market trends shaping the new landscape to support better decisions for the long and short-term future.

What are the biggest opportunities for growth in the Deep Brain Stimulation in Parkinson's Disease industry?

The Deep Brain Stimulation in Parkinson's Disease sector demonstrated remarkable resilience over the past year across developed and developing economies. Further, the market presents significant opportunities to leverage the existing momentum towards actions by 2030. On the other hand, recent macroeconomic developments including rising inflation and supply chain disruptions are putting pressure on companies. The chapter assists users to identify growth avenues and address business challenges to make informed commercial decisions with unique insights, data forecasts, and in-depth market analyses.

Deep Brain Stimulation in Parkinson's Disease Market Segment Insights

The Deep Brain Stimulation in Parkinson's Disease industry presents strong offers across categories. The analytical report offers forecasts of Deep Brain Stimulation in Parkinson's Disease industry performance across segments and countries. Key segments in the industry include- By Product (Single Channel, Dual Channel), By End-User (Hospitals, Neurology Clinics, Ambulatory Surgical Centers, Research Centers). The largest types, applications, and sales channels, fastest growing segments, and the key factors driving each of the categories are included in the report.

Forecasts of each segment across five regions are provided from 2021 through 2032 for Asia Pacific, North America, Europe, South America, Middle East, and African regions. In addition, Deep Brain Stimulation in Parkinson's Disease market size outlook is provided for 22 countries across these regions.

Market Value Chain

The chapter identifies potential companies and their operations across the global Deep Brain Stimulation in Parkinson's Disease industry ecosystem. It assists decision-makers in evaluating global Deep Brain Stimulation in Parkinson's Disease market fundamentals, market dynamics, and disruptive trends across the value chain segments.

Scenario Analysis and Forecasts

Strategic decision-making in the Deep Brain Stimulation in Parkinson's Disease industry is multi-faceted with the increased need for planning across scenarios. The report provides forecasts across three case scenarios- low growth, reference case, and high growth cases.

Asia Pacific Deep Brain Stimulation in Parkinson's Disease Market Analysis- A Promising Growth Arena for Business Expansion

As companies increasingly expand across promising Asia Pacific markets with a combined population of over 4.5 billion, the medium-to-long-term future remains robust. The presence of the fastest-growing economies such as China, India, Thailand, Indonesia, and Vietnam coupled with strengthening middle-class populations and rising disposable incomes drive the market. In particular, China and India are witnessing rapid shifts in consumer purchasing behavior. China is recovering steadily with optimistic forecasts for 2025. Further, Japanese and South Korean markets remain stable with most companies focusing on new product launches and diversification of sales channels.

The State of Europe Deep Brain Stimulation in Parkinson's Disease Industry 2025- Focus on Accelerating Competitiveness

As companies opt for an integrated agenda for competitiveness, the year 2025 presents optimistic scenarios for companies across the ecosystem. With signs of economic recovery across markets, companies are increasing their investments. Europe is one of the largest markets for Deep Brain Stimulation in Parkinson's Disease with demand from both Western Europe and Eastern European regions increasing over the medium to long-term future. Increasing omnichannel shopping amidst robust consumer demand for value purchases shapes the market outlook. The report analyses the key Deep Brain Stimulation in Parkinson's Disease market drivers and opportunities across Germany, France, the United Kingdom, Spain, Italy, Russia, and other Europe.

The US Deep Brain Stimulation in Parkinson's Disease market Insights- Executives are most excited about opportunities for the US Deep Brain Stimulation in Parkinson's Disease industry.

Easing inflation coupled with strengthening consumer sentiment is encouraging aggressive actions from the US Deep Brain Stimulation in Parkinson's Disease companies. Market players consistently focusing on innovation and pursuing new ways to create value are set to excel in 2025. In addition, the Canadian and Mexican markets offer lucrative growth pockets for manufacturers and vendors. Focus on private-brand offerings and promotions, diversified sales channels, expansion into niche segments, adoption of advanced technologies, and sustainability are widely observed across the North American Deep Brain Stimulation in Parkinson's Disease market.

Latin American Deep Brain Stimulation in Parkinson's Disease market outlook rebounds in line with economic growth.

Underlying demand remains higher among urban consumers with an optimistic economic outlook across Brazil, Argentina, Chile, and other South and Central American countries. Increased consumer spending has been reported since H2-2024 and the prospects remain strong for 2025. Aggressive ecosystem moves to create new sources of income are widely observed across markets in the region. Marketing activities focused on customer insights, operations, and support functions are quickly gaining business growth in the region.

Middle East and Africa Deep Brain Stimulation in Parkinson's Disease Markets- New Opportunities for Companies Harnessing Diversity

Rapid growth in burgeoning urban locations coupled with a young and fast-growing population base is attracting new investments in the Middle East and African Deep Brain Stimulation in Parkinson's Disease markets. Designing expansion and marketing strategies to cater to the local consumer base supports the market prospects. In addition to Nigeria, Algeria, South Africa, and other markets, steady growth markets in Ethiopia, Rwanda, Ghana, Tanzania, the Democratic Republic of Congo, and others present significant prospects for companies. On the other hand, Middle Eastern Deep Brain Stimulation in Parkinson's Disease markets including the UAE, Saudi Arabia, Qatar, and Oman continue to offer lucrative pockets of growth.

Competitive Landscape- How Deep Brain Stimulation in Parkinson's Disease companies outcompete in 2025?

The ability to respond quickly to evolving consumer preferences and adapt businesses to niche consumer segments remains a key growth factor. The report identifies the leading companies in the industry and provides their revenue for 2024. The market shares of each company are also included in the report. Further, business profiles, SWOT analysis, and financial analysis of each company are provided in detail. Key companies analyzed in the report include Abbott Laboratories, Aleva Neurotherapeutics SA, Beijing Pins Medical Co. Ltd, Boston Scientific Corp, Functional Neuromodulation Ltd, General Electric Co., Medtronic PLC, MicroTransponder Inc, Neuronetics Inc, NeuroPace Inc, NeuroSigma Inc, Nexstim Oy, Renishaw PLC, Siemens AG, St. Jude Medical nc., Synapse Biomedical Inc.

Reasons to Buy the report

  • Make informed decisions through long and short-term forecasts across 22 countries and segments.
  • Evaluate market fundamentals, dynamics, and disrupting trends set to shape 2025 and beyond.
  • Gain a clear understanding of the competitive landscape, with product portfolio and growth strategies.
  • Get an integrated understanding of the entire market ecosystem and companies.
  • Stay ahead of the competition through plans for growth in a changing environment for your geographic expansion.
  • Assess the impact of advanced technologies and identify growth opportunities based on actionable data and insights.
  • Get free Excel spreadsheet and PPT versions along with the report PDF.


1. Table of Contents
List of Figures and Tables
2. Executive Summary
2.1 Key Highlights
2.1.1 Deep Brain Stimulation in Parkinson's Disease Market Size Outlook, 2018-2024 and 2025-2032
2.1.2 Largest Deep Brain Stimulation in Parkinson's Disease Market Types and Applications
2.1.3 Fastest Growing Segments
2.1.4 Potential Markets
2.1.5 Market Concentration
2.2 Market Scope and Segmentation
2.2.1 Market Scope- Segments
2.2.2 Market Scope- Countries
2.2.3 Macroeconomic and Demographic Outlook
2.2.4 Abbreviations
2.2.5 Units and Currency Conversions
3. Research Methodology
3.1 Primary Research Surveys
3.2 Secondary Data Sources
3.3 Data Triangulation
3.4 Forecast Methodology
3.5 Assumptions and Limitations
4. Introduction to Global Deep Brain Stimulation in Parkinson's Disease Market in 2025
4.1 Industry Panorama
4.2 Leading Companies Profiled in the Study
4.3 Asia Pacific Markets offer Robust Market Prospects for New Entrants
4.4 Market Dynamics
4.4.1 Market Dynamics- Trends and Drivers
4.4.2 Market Dynamics- Opportunities and Challenges
4.5 Regional Analysis
4.6 Porter’s Five Force Analysis
4.6.1 Intensity of Competitive Rivalry
4.6.2 Threat of New Entrants
4.6.3 Threat of Substitutes
4.6.4 Bargaining Power of Buyers
4.6.5 Bargaining Power of Suppliers
4.7 Deep Brain Stimulation in Parkinson's Disease Industry Value Chain Analysis
4.7.1 Stage of Value Chain
4.7.2 Key Activities of Companies
4.7.3 Companies Included in Each Stage
4.7.4 Key Insights
5. Deep Brain Stimulation in Parkinson's Disease Market Outlook to 2032
5.1 Market Size Forecast by Type, 2021-2024 and 2025-2032
5.2 Market Size Forecast by Application, 2021-2024 and 2024-2032
5.3 Market Size Forecast by Geography, 2021-2024 and 2024-2032
By Product
Single Channel
Dual Channel
By End-user
Hospitals
Neurology Clinics
Ambulatory Surgical Centers
Research Centers
6. Global Deep Brain Stimulation in Parkinson's Disease Market Outlook across Growth Scenarios
6.1 Low Growth Scenario
6.2 Base/Reference Case
6.3 High Growth Scenario
6. North America Deep Brain Stimulation in Parkinson's Disease Market Size Outlook
6.1 Key Market Statistics, 2024
6.2 North America Deep Brain Stimulation in Parkinson's Disease Market Trends and Growth Opportunities
6.2.1 North America Deep Brain Stimulation in Parkinson's Disease Market Outlook by Type
6.2.2 North America Deep Brain Stimulation in Parkinson's Disease Market Outlook by Application
6.3 North America Deep Brain Stimulation in Parkinson's Disease Market Outlook by Country
6.3.1 The US Deep Brain Stimulation in Parkinson's Disease Market Outlook, 2021- 2032
6.3.2 Canada Deep Brain Stimulation in Parkinson's Disease Market Outlook, 2021- 2032
6.3.3 Mexico Deep Brain Stimulation in Parkinson's Disease Market Outlook, 2021- 2032
7. Europe Deep Brain Stimulation in Parkinson's Disease Market Size Outlook
7.1 Key Market Statistics, 2024
7.2 Europe Deep Brain Stimulation in Parkinson's Disease Market Trends and Growth Opportunities
7.2.1 Europe Deep Brain Stimulation in Parkinson's Disease Market Outlook by Type
7.2.2 Europe Deep Brain Stimulation in Parkinson's Disease Market Outlook by Application
7.3 Europe Deep Brain Stimulation in Parkinson's Disease Market Outlook by Country
7.3.2 Germany Deep Brain Stimulation in Parkinson's Disease Market Outlook, 2021- 2032
7.3.3 France Deep Brain Stimulation in Parkinson's Disease Market Outlook, 2021- 2032
7.3.4 The UK Deep Brain Stimulation in Parkinson's Disease Market Outlook, 2021- 2032
7.3.5 Spain Deep Brain Stimulation in Parkinson's Disease Market Outlook, 2021- 2032
7.3.6 Italy Deep Brain Stimulation in Parkinson's Disease Market Outlook, 2021- 2032
7.3.7 Russia Deep Brain Stimulation in Parkinson's Disease Market Outlook, 2021- 2032
7.3.8 Rest of Europe Deep Brain Stimulation in Parkinson's Disease Market Outlook, 2021- 2032
8. Asia Pacific Deep Brain Stimulation in Parkinson's Disease Market Size Outlook
8.1 Key Market Statistics, 2024
8.2 Asia Pacific Deep Brain Stimulation in Parkinson's Disease Market Trends and Growth Opportunities
8.2.1 Asia Pacific Deep Brain Stimulation in Parkinson's Disease Market Outlook by Type
8.2.2 Asia Pacific Deep Brain Stimulation in Parkinson's Disease Market Outlook by Application
8.3 Asia Pacific Deep Brain Stimulation in Parkinson's Disease Market Outlook by Country
8.3.1 China Deep Brain Stimulation in Parkinson's Disease Market Outlook, 2021- 2032
8.3.2 India Deep Brain Stimulation in Parkinson's Disease Market Outlook, 2021- 2032
8.3.3 Japan Deep Brain Stimulation in Parkinson's Disease Market Outlook, 2021- 2032
8.3.4 South Korea Deep Brain Stimulation in Parkinson's Disease Market Outlook, 2021- 2032
8.3.5 Australia Deep Brain Stimulation in Parkinson's Disease Market Outlook, 2021- 2032
8.3.6 South East Asia Deep Brain Stimulation in Parkinson's Disease Market Outlook, 2021- 2032
8.3.7 Rest of Asia Pacific Deep Brain Stimulation in Parkinson's Disease Market Outlook, 2021- 2032
9. South America Deep Brain Stimulation in Parkinson's Disease Market Size Outlook
9.1 Key Market Statistics, 2024
9.2 South America Deep Brain Stimulation in Parkinson's Disease Market Trends and Growth Opportunities
9.2.1 South America Deep Brain Stimulation in Parkinson's Disease Market Outlook by Type
9.2.2 South America Deep Brain Stimulation in Parkinson's Disease Market Outlook by Application
9.3 South America Deep Brain Stimulation in Parkinson's Disease Market Outlook by Country
9.3.1 Brazil Deep Brain Stimulation in Parkinson's Disease Market Outlook, 2021- 2032
9.3.2 Argentina Deep Brain Stimulation in Parkinson's Disease Market Outlook, 2021- 2032
9.3.3 Rest of South and Central America Deep Brain Stimulation in Parkinson's Disease Market Outlook, 2021- 2032
10. Middle East and Africa Deep Brain Stimulation in Parkinson's Disease Market Size Outlook
10.1 Key Market Statistics, 2024
10.2 Middle East and Africa Deep Brain Stimulation in Parkinson's Disease Market Trends and Growth Opportunities
10.2.1 Middle East and Africa Deep Brain Stimulation in Parkinson's Disease Market Outlook by Type
10.2.2 Middle East and Africa Deep Brain Stimulation in Parkinson's Disease Market Outlook by Application
10.3 Middle East and Africa Deep Brain Stimulation in Parkinson's Disease Market Outlook by Country
10.3.1 Saudi Arabia Deep Brain Stimulation in Parkinson's Disease Market Outlook, 2021- 2032
10.3.2 The UAE Deep Brain Stimulation in Parkinson's Disease Market Outlook, 2021- 2032
10.3.3 Rest of Middle East Deep Brain Stimulation in Parkinson's Disease Market Outlook, 2021- 2032
10.3.4 South Africa Deep Brain Stimulation in Parkinson's Disease Market Outlook, 2021- 2032
10.3.5 Egypt Deep Brain Stimulation in Parkinson's Disease Market Outlook, 2021- 2032
10.3.6 Rest of Africa Deep Brain Stimulation in Parkinson's Disease Market Outlook, 2021- 2032
11. Company Profiles
11.1 Leading 10 Companies
Abbott Laboratories
Aleva Neurotherapeutics SA
Beijing Pins Medical Co. Ltd
Boston Scientific Corp
Functional Neuromodulation Ltd
General Electric Co.
Medtronic PLC
MicroTransponder Inc
Neuronetics Inc
NeuroPace Inc
NeuroSigma Inc
Nexstim Oy
Renishaw PLC
Siemens AG
St. Jude Medical nc.
Synapse Biomedical Inc
11.2 Overview
11.3 Products and Services
11.4 SWOT Profile
12. Appendix
12.1 Subscription Options
12.2 Customization Options
12.3 Publisher Details

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings